Wireless sensors to monitor immune responses in tumors
Implantable Nanophotonic Sensors for in Vivo Immunoresponse
This study is testing a new tiny sensor that can be placed inside tumors to help doctors see how your immune system is reacting to cancer treatments, so you can get more personalized and effective care.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project ID | NIH-10002722 on NIH RePORTER |
What this research studies
This research focuses on developing a groundbreaking implantable sensor that can visualize real-time immune responses within a patient's tumor microenvironment. By utilizing advanced technology, the sensor acts like a wireless biopsy, providing critical insights into how tumors respond to treatments such as immunotherapy. Patients will benefit from personalized care as the sensor allows for continuous monitoring of tumor biology and immune activity, potentially leading to more effective treatment strategies. The approach combines innovative microfabrication techniques with wireless data transfer to create a compact, powerful tool for cancer management.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with various types of tumors who are undergoing treatment and could benefit from real-time monitoring of their immune response.
Not a fit: Patients with non-tumor related conditions or those who are not undergoing any form of cancer treatment may not receive benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to more personalized and effective cancer treatments by providing real-time insights into tumor responses.
How similar studies have performed: Other research has shown promise in using implantable sensors for monitoring biological responses, indicating potential success for this novel approach.
Where this research is happening
San Francisco, United States
- University of California, San Francisco — San Francisco, United States (Active)
Researchers
- Principal investigator: Anwar, Mekhail — University of California, San Francisco
- Study coordinator: Anwar, Mekhail
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.